Table 1 Clinical characteristics of the NPC patients
From: Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis
Characteristics | N (%)/median (IQR) | Leptin | p-value | |
|---|---|---|---|---|
Low (n = 28) | High (n = 22) | |||
Age | 50(42–60) | 54.5(45.3–61.0) | 53.5(41.8–60.3) | 0.615 |
Gender | ||||
Female | 13(26.0%) | 9(32.1%) | 4(18.2%) | 0.264 |
Male | 37(74.0%) | 19(67.9%) | 18(81.8%) | |
AJCC stage | ||||
I | 8(16.0%) | 8(28.6%) | 0(0.0%) | < 0.001* |
II | 11(22.0%) | 10(35.7%) | 1(4.5%) | |
III | 7(14.0%) | 6(21.4%) | 1(4.5%) | |
IV | 24(48.0%) | 4(14.3%) | 20(90.9%) | |
T stage | ||||
1 | 14(28.0%) | 13(46.4%) | 1(4.5%) | < 0.001* |
2 | 17(34.0%) | 13(46.4%) | 4(18.2%) | |
3 | 1(2.0%) | 0(0.0%) | 1(4.5%) | |
4 | 18(36.0%) | 2(7.1%) | 16(72.7%) | |
N stage | ||||
0 | 19(38.0%) | 17(60.7%) | 2(9.1%) | < 0.001* |
1 | 12(24.0%) | 3(10.7%) | 9(40.9%) | |
2 | 14(28.0%) | 7(25.0%) | 7(31.8%) | |
3 | 5(10.0%) | 1(3.6%) | 4(18.2%) | |
M stage | ||||
0 | 25(78.1%) | 13(81.3%) | 12(75.0%) | 1.000 |
1 | 7(21.9%) | 3(18.8%) | 4(25.0%) | |
T stage | ||||
1&2 | 31(62.0%) | 26(92.9%) | 5(22.7%) | < 0.001* |
3&4 | 19(38.0%) | 2(7.1%) | 17(77.3%) | |
N stage | ||||
0 | 19(38.0%) | 17(60.7%) | 2(9.1%) | < 0.001* |
1&2&3 | 31(62.0%) | 11(39.3%) | 20(90.9%) | |
AJCC stage | ||||
I & II | 19(38.0%) | 18(64.3%) | 1(4.5%) | < 0.001* |
III & IV | 31(62.0%) | 10(35.7%) | 21(95.5%) | |
Pre-RTO BMI | 24.46(21.59–26.93) | 24.17(19.97–27.06) | 23.59(21.04–26.49) | 0.749 |